Daily non-political popular news in brief.

New therapy effectively treats deep vein thrombosis

A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study. The study found that injecting or "lacing" the clot with a fiber-binding thrombolytic agent effectively treats deep vein thrombosis and reduces the risk of subsequent recurrence or bleeding.

Read more »

Keywords: therapy, effectively, treats, deep, vein, thrombosis, treat, thrombosi

« Previous | Next »

Similar news on "New therapy effectively treats deep vein thrombosis":

1. Research aims to identify markers for menopausal women at risk for deadly blood clot
   08-08-2007 · EurekAlert!
   In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein. Although the disorder is rare, it increases exponentially during menopause and can be deadly. Hormone trials conducted thus far, focusing on proteins in blood coagulation, have not yet led to a risk profile, precluding identification of women at risk. Mayo Clinic researchers have now developed a novel concept that uses blood platelets to define thrombotic risk.
   Similar news · Read more »
   
2. Jefferson scientists find high glucose before surgery raises risk of dangerous complications
   10-15-2006 · EurekAlert!
   When researchers examined records of nearly 6,500 hip or knee replacement surgery patients who were treated at Thomas Jefferson University Hospital between 2003 and 2005, they found that those who had high blood sugar before undergoing surgery ran an increased risk of developing blood clots, deep vein thrombosis and even pulmonary embolism after surgery.
   Similar news · Read more »
   
3. Novel drug preventing protein recycling shows potential for treating leukemia
   04-19-2007 · EurekAlert!
   Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.
   Similar news · Read more »
   
4. New compound effectively treats fungal infections
   06-22-2007 · EurekAlert!
   A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory (EMBL) outstation in Grenoble, France. In the current issue of Science they describe how a new compound kills fungal pathogens by blocking an enzyme crucial for their protein synthesis.
   Similar news · Read more »
   
5. Hormone drug type makes survival difference in advanced breast cancer
   01-30-2007 · EurekAlert!
   Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.
   Similar news · Read more »
   
6. Ultrathin films deliver DNA as possible gene therapy tool
   03-26-2007 · EurekAlert!
   Gene therapy -- the idea of using genetic instructions rather than drugs to treat disease -- has tickled scientists' imaginations for decades, but is not yet a viable therapeutic method. One sizeable hurdle is getting the right genes into the right place at the right time. Engineers at the University of Wisconsin-Madison are now developing a tool to tackle this problem.
   Similar news · Read more »
   
7. Risk and outcome similar for bypass surgery, drug-eluting stents
   04-19-2007 · EurekAlert!
   Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
   Similar news · Read more »
   
8. Experimental drug shows promise in advanced kidney cancer
   09-26-2007 · EurekAlert!
   A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
   Similar news · Read more »
   
9. Safe and effective therapy discovered for patients with protein-losing enteropathy
   12-06-2007 · EurekAlert!
   A study performed by the laboratory of Hudson Freeze, Ph.D., at the Burnham Institute has been published in the Journal of Clinical Investigation, describing both the science behind protein-losing enteropathy and also a way to treat the disease that side steps some of the severe complications of current treatments.
   Similar news · Read more »
   
10. Experimental MS drug shows promise, offers new window on disease
    02-13-2008 · EurekAlert!
    A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
    Similar news · Read more »